Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3188)	1/2/2014 5:53:41 PM
From: Jibacoa	Respond to of 3722

BIOD was up 21.49% ona volume around 8x its ADV and has continued to do OK AHs. It also has some products for Diabetes.<g> It is involved in developing proprietary formulations of injectable recombinant human insulin for the treatment of patients with type 1 and type 2 diabetes. It also develops liquid glucagon formulations for use as a rescue treatment for diabetes patients experiencing severe hypoglycemia, BIOD has close to $40M in cash and no significant LTD, albeit it has been burning its cash at a good clip.<g> The insiders had been doing some selling lately, but the institutions that hold around 60% of the shares had been adding some more and there is a good short position, which could help the stock. .<g> It seems that with some good news the stock can retest its late June H at the $6 level.<g> bigcharts.marketwatch.com Bernard